Color Tuneable Bio-Sensor Made Up From Stimuli-Responsive Nanoparticles

2016 ◽  
Vol 4 (1) ◽  
pp. 06-07
Author(s):  
Aashish Agarwal
Keyword(s):  
Health Care ◽  
Visible Region ◽  
Biological Response ◽  
Health Care Industry ◽  
Clinical Analysis ◽  
Electrical Signal ◽  
Stimuli Responsive ◽  
Care Industry ◽  
Wide Range ◽  
Protein Sensor

A biosensor is a device that is made up of transducer and biological elements [1-3]. The biological elements can be proteins, enzymes or antibodies [1]. The biological elements interact with the analyte which convert the biological response to an electrical signal. So usually biosensor consists of a biological component (acting as a sensor) and an electrical component (for detecting and transmitting the signal). Biosensors have a wide range of applications in different areas of science such as health care industry, clinical analysis and diagnosis of disease and agriculture [4]. In particular, there is a growing interest to prepare bio-sensor using different types of nanomaterials such as gold nanoparticles, carbon nanotubes, quantum dots, etc. [4].In the current proposal, we plan to prepare a low cost protein-sensor using polymeric stimuli-responsive nanoparticles based on diffraction principle. Moreover, this sensor will have a switchable functionality towards pH, temperature and electric field and also can be used with high accuracy of proteins detection based on a simple diffraction principle in the visible region. Since the awareness regarding health and wellbeing is increasing day by day in the global population, the use of biosensors in diagnostics is also simultaneously growing. Thus we believe that our proposed protein sensor based on diffraction principle will also have a popular demand in health care industry. 

Sexism and Racism in the American Health Care Industry: A Comparative Analysis

1978 ◽  
Vol 8 (4) ◽  
pp. 677-703 ◽  
Author(s):  
Jerry L. Weaver ◽  
Sharon D. Garrett
Keyword(s):  
Health Care ◽  
Comparative Analysis ◽  
Ethnic Minorities ◽  
Health Care Industry ◽  
Professional Schools ◽  
Remarkable Similarity ◽  
Care Industry ◽  
Wide Range ◽  
American Health Care

By drawing on a wide range of material, a picture emerges of extensive abuse, discrimination, and exploitation of women and ethnic minorities at the hands of the American health industry. The numbers of minorities and women in professional schools and among the “elite” strata of the industry remain disproportionately low. As patients, they receive often inferior, insensitive treatment. Overall, there is a remarkable similarity in the situation of women and minorities, a condition which reflects the pervasiveness of racism and sexism in American institutions and ideologies.

scholarly journals Stem Cell Management is a Novel Innovation in the Health Care Sector. The Study Based on Research Conducted by Professionals in the Field

2021 ◽  
pp. 253-262
Author(s):  
Swati Chaudhary ◽  
Supriti Agrawal
Keyword(s):  
Health Care ◽  
Clinical Trials ◽  
Stem Cell ◽  
Health Professional ◽  
Health Care Industry ◽  
Secondary Data ◽  
World Health ◽  
Care Industry ◽  
Wide Range ◽  
The World

Background: A physician offers treatments to prevent, treat, and manage sickness and to maintain mental and physical well-being. According to the World Health Organization, health care includes all raw materials and services aimed to enhance health, including "preventative health, therapeutic, and supportive interventions, either aimed to people either to nations." Stem cell is one of the innovations of health care industry. Stem cells are used to treat over 130 diseases throughout the world, and more than 500 clinical trials are ongoing to develop stem cell treatments. Henceforth, this paper aim is to enhance the stem cell role in health care industry and to find the health professional attitude towards stem cell management. Methods: For the study purpose both primary and secondary data are used. The cross sectional study conducted among 140 doctors of the Delhi-NCR for the primary data. The secondary data collected from records of the WHO, various journals, scientific study and clinical trials. The data were analysis by the using the correlation and t-test by SPSS 21 software to find the attitude of doctors towards stem cell management. Results: The study found that 97% of doctors are aware about the stem cell and 86% doctors have knowledge about the sources of stem cell and only 25% doctors collect the stem cell from umbilical cord. The study determine that the attitude of the health professional are positive towards stem cell management in India and they need government takes necessary action to developed the stem cell management for better health sector in India. Conclusions: Thus it can be concluded that with the increases of the cases the scientists try to find the use of stem cell in the treatment of various diseases. It does clearly indicate that stem cell boost the immune system. The data analysis of the study confirms that doctors in India have a positive view toward stem cell management. As a result, if sufficient initiative is made by healthcare professionals and the government, stem cell management has a wide range of adoption and acceptance opportunities.

scholarly journals Exploring the Social Networks’ Use in the Health-Care Industry: A Multi-Level Analysis

2021 ◽  
Vol 18 (14) ◽  
pp. 7295
Author(s):  
Tommasina Pianese ◽  
Patrizia Belfiore
Keyword(s):  
Health Care ◽  
Social Networks ◽  
Health Care Providers ◽  
Health Care Industry ◽  
Future Research ◽  
Great Level ◽  
Care Providers ◽  
Care Industry ◽  
Multi Level ◽  
Video And Audio

The application of social networks in the health domain has become increasingly prevalent. They are web-based technologies which bring together a group of people and health-care providers having in common health-related interests, who share text, image, video and audio contents and interact with each other. This explains the increasing amount of attention paid to this topic by researchers who have investigated a variety of issues dealing with the specific applications in the health-care industry. The aim of this study is to systematize this fragmented body of literature, and provide a comprehensive and multi-level overview of the studies that has been carried out to date on social network uses in healthcare, taking into account the great level of diversity that characterizes this industry. To this end, we conduct a scoping review enabling to identify the major research streams, whose aggregate knowledge are discussed according to three levels of analysis that reflect the viewpoints of the major actors using social networks for health-care purposes, i.e., governments, health-care providers (including health-care organizations and professionals) and social networks’ users (including ill patients and general public). We conclude by proposing directions for future research.

scholarly journals A Review on Biosensors and Recent Development of Nanostructured Materials-Enabled Biosensors

Sensors ◽  
2021 ◽  
Vol 21 (4) ◽  
pp. 1109
Author(s):  
Varnakavi. Naresh ◽  
Nohyun Lee
Keyword(s):  
High Surface ◽  
Three Dimensional ◽  
Biological Response ◽  
Volume Ratio ◽  
Recent Decade ◽  
Disease Diagnosis ◽  
Electrical Signal ◽  
Detection Sensitivity ◽  
Wide Range ◽  
Color Tunability

A biosensor is an integrated receptor-transducer device, which can convert a biological response into an electrical signal. The design and development of biosensors have taken a center stage for researchers or scientists in the recent decade owing to the wide range of biosensor applications, such as health care and disease diagnosis, environmental monitoring, water and food quality monitoring, and drug delivery. The main challenges involved in the biosensor progress are (i) the efficient capturing of biorecognition signals and the transformation of these signals into electrochemical, electrical, optical, gravimetric, or acoustic signals (transduction process), (ii) enhancing transducer performance i.e., increasing sensitivity, shorter response time, reproducibility, and low detection limits even to detect individual molecules, and (iii) miniaturization of the biosensing devices using micro-and nano-fabrication technologies. Those challenges can be met through the integration of sensing technology with nanomaterials, which range from zero- to three-dimensional, possessing a high surface-to-volume ratio, good conductivities, shock-bearing abilities, and color tunability. Nanomaterials (NMs) employed in the fabrication and nanobiosensors include nanoparticles (NPs) (high stability and high carrier capacity), nanowires (NWs) and nanorods (NRs) (capable of high detection sensitivity), carbon nanotubes (CNTs) (large surface area, high electrical and thermal conductivity), and quantum dots (QDs) (color tunability). Furthermore, these nanomaterials can themselves act as transduction elements. This review summarizes the evolution of biosensors, the types of biosensors based on their receptors, transducers, and modern approaches employed in biosensors using nanomaterials such as NPs (e.g., noble metal NPs and metal oxide NPs), NWs, NRs, CNTs, QDs, and dendrimers and their recent advancement in biosensing technology with the expansion of nanotechnology.

Antitrust Implications of Health Planning: National Gerimedical Hospital and Gerontology Center v. Blue Cross of Kansas City

1982 ◽  
Vol 8 (3) ◽  
pp. 321-348
Author(s):  
Judy B. Chase
Keyword(s):  
Health Care ◽  
Kansas City ◽  
Health Planning ◽  
United States Supreme Court ◽  
Health Care Industry ◽  
The United States ◽  
United States Supreme ◽  
Planning Activity ◽  
Care Industry ◽  
Antitrust Laws

AbstractIn National Gerimedical Hospital and Gerontology Center v. Blue Cross of Kansas City, the United States Supreme Court held that there is no blanket exemption from antitrust laws for health planning activities.‘The Court also held that no specific immunity can be granted where the challenged health planning activity is not undertaken pursuant to a federal regulatory scheme. This Comment reviews the Court’s decision and concludes that the Court correctly determined that the challenged activities did not qualify for an exemption. The Comment also examines the implications of the Court's statement that, where Congress has manifested a belief that competition is ineffective in the health care industry, application of the antitrust laws should be modified. The Comment recommends that an intermediate review standard such as the “presumptive, incentive modifying approach” should be used by future courts in deciding whether the ineffectiveness of competition in a given area of health planning activity warrants immunity from antitrust scrutiny.

Sign in / Sign up

Export Citation Format

Share Document